GLP1R and pulmonary arterial hypertension: It has been proposed that this would result in inappropriately elevated levels of type 1 glucagon-like peptide (GLP-1) and insulin, which, in association with possible reductions in the release of counter-regulatory hormones, could cause episodes of PPH (8-10).